The death was reported from Kurukshetra district
Amid a rise in COVID-19 cases, the Delhi Disaster Management Authority on Tuesday ordered the closure of schools, colleges, cinemas and gyms with immediate effect
The Arvind Kejriwal government took the decision after the Covid-19 positivity rate in the capital rose to 0.55 per cent on Sunday and 0.68 per cent on Monday
DTC and other city buses shall also ply with only 50 per cent of the total seating capacity in view of the new norms
The agenda of the meeting is to review the Covid-19 situation in Delhi and discuss preparations in the wake of rising Omicron cases
Of the seven cases, four were detected in Pathanamthitta, two in Alappuzha and one in Thiruvananthapuram
With the authorities imposing fresh Covid restrictions in Delhi on Tuesday, traders said it will be a "death warrant" for the fitness industry and make a "big dent" in their businesses.
The CDSCO has granted restricted emergency use authorisation to two new vaccines and a drug for Covid-19, taking to 12 the number of preventives and treatments available in India
Xi'an, capital of China's Shaanxi Province reported 175 confirmed locally transmitted Covid cases on Monday, taking the total tally to 811 amid the surge in coronavirus cases, local media reported.
A team of international researchers have shown that SARS-CoV-2, virus causing Covid-19, infects the kidneys and contributes to tissue scarring, possibly impacting kidney outcomes in the long term.
The Hyderabad-based firm said it will introduce the drug under the brand name Molflu in India
Hetero said it has received permission from DCGI for manufacturing and marketing Molnupiravir capsules of 200 mg strength that is used to treat high-risk Covid adult patients.
Spas, gyms, yoga institutes and entertainment parks will remain closed, but outdoor yoga will be allowed
Night curfew will be imposed from 10 pm to 5 am; Delhi Metro, restaurants, bars to operate at 50% capacity
The Drugs Controller General of India (DCGI), based on the review of clinical data of Molnupiravir has approved the drug for the treatment of Covid-19 in adults for restricted emergency use in India
People aged 60 years and above with co-morbidities, who have received two doses of Covid vaccine, will on doctor's advice be provided with the precaution dose from Jan 10
The Hyderabad-based vaccine maker has already approached the Drug Controller General of India (DCGI) for approval to conduct phase-III trials of its intranasal vaccine
The DCGI has approved molnupiravir for treatment of adult patients with Covid and who have high risk of progression of the disease including hospitalisation or death
A new study led by an international team of researchers from South Africa, the US and Germany has now shown that the vaccine evading Omicron enhances neutralising immunity of the Delta variant
Amid the Omicron scare, Delhi recorded 331 fresh coronavirus cases, the highest single-day rise since June 9 and one death, on Monday